Johns Hopkins University: Macular Degeneration trials
The registry lists 12 Macular Degeneration studies with Johns Hopkins University as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 1 2Phase 2 3Phase 3 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) PilotCompletedNCT00605423Phase 2Results posted
- Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular DegenerationTerminatedNCT05038371
- Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular DegenerationTerminatedNCT03699618
- Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) TherapyCompletedNCT03065907Not applicable
- Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic RetinopathyTerminatedNCT02875704
- The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular DystrophyCompletedNCT02410122
- NVAMD Satellite StudyCompletedNCT02251366Not applicable
- Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular DegenerationCompletedNCT01570790Phase 1/2
- Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)TerminatedNCT01337414Not applicable
- Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)CompletedNCT00417846
- Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)CompletedNCT00407719Phase 1
- Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)CompletedNCT00305630Phase 2/3